中文

To empower the entire workflow for imaging, screening, follow-up, diagnosis, therapy, and assessment of multiple diseases.

United Imaging Intelligence (UII) Co., Ltd. is a member company of United Imaging Healthcare Technology Group. Founded in 2017 in Shanghai, UII has gathered some of the world’s top talents in medical AI, and built up a strong team with more than 80% of employees dedicated to R&D. By leveraging the technical strength and rich resource of UIH Group, UII is able to innovate into multiple dimensions, and push for the broadest applications of AI in the medical imaging and healthcare domain.

United Imaging Healthcare Technology Group Co. Ltd. (United Imaging Group) is a global leader in healthcare technology. With innovative solutions from prevention to diagnosis, treatment, and rehabilitation, United Imaging Group aims to build an intelligent healthcare ecosystem to benefit patients all over the world.

Supported by the Central Research Institute and subsidiaries, United Imaging Group develops and produces a full portfolio of advanced medical imaging and radiotherapy equipment, medical robots, smart wearables, e-medicine, medical artificial intelligence (AI) solutions, Digital Orthopedics, and third-party precision medical diagnosis center services.

STARTING
FROM THE SOURCE

To empower all modalities of advanced medical imaging devices to make imaging faster, better, and safer.

FULL
STACK

To empower the entire workflow for imaging, screening, follow-up, diagnosis, therapy, and assessment.

FULL
SPECTRUM

To provide AI solutions for multiple diseases such as ICH, neurodegenerative diseases, pulmonary nodules, among others. To enable diagnosis of multiple diseases in one scan.

OPEN PLATFORM
&ECOSYSTEM

To enable development of new AI applications among users
in the fields of clinical practice and research.

VISION

Leading Medical AI Innovation.

MISSION

To Bring Equal Healthcare for All.

GLOBAL
R&D MAP

Our headquarters is located in Shanghai, and we have branches/subsidiaries in Beijing, Wuhan, Chengdu and Boston(USA), and plans to set up R&D teams in Xi’an and Shenzhen.